• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Structure Therapeutics Inc. - American Depositary Shares (NQ:GPCR)

    38.91 -0.28 (-0.71%)
    Streaming Delayed Price Updated: 2:12 PM EDT, May 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 144,613
    Open 39.19
    Bid (Size) 38.84 (100)
    Ask (Size) 38.98 (100)
    Prev. Close 39.19
    Today's Range 38.05 - 39.50
    52wk Range 15.80 - 94.90
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million ↗
    Structure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary conditions. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter ↗
    This biotechnology firm develops clinical-stage therapies for autoimmune and neuroinflammatory diseases using proprietary TYK2 inhibitors. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -42.9%
    -42.9%
    1 Month
    -14.2%
    -14.2%
    3 Month
    -42.0%
    -42.0%
    6 Month
    +10.2%
    +10.2%
    1 Year
    +63.1%
    +63.1%

    More News

    Read More
    News headline image
    Monashee Scales Back Its Bet on Structure Therapeutics ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
    From Structure Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions
    From Structure Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    3 Ways to Invest in the Growing GLP-1 Weight Loss Market ↗
    Via MarketBeat
    News headline image
    Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel
    From Structure Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    The Great Metabolic Land Grab: Why Viking and Structure Have Become Big Pharma’s 'Irresistible' Targets
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
    Via MarketMinute
    Topics Economy
    News headline image
    Main Street’s Revenge: The Great Rotation of 2026 Rewrites Market History
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    The Great Rotation: Small-Caps Seize Market Leadership in Historic 2026 Breakout
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    The Great Rotation: Russell 2000 Outshines Mega-Caps as Domestic Small-Caps Take the Reins in 2026
    Via MarketMinute
    Topics Artificial Intelligence Economy World Trade
    News headline image
    Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges ↗
    Via The Motley Fool
    News headline image
    3 Companies at the Forefront of the GLP-1 Pill Wars ↗
    Via MarketBeat
    News headline image
    Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
    From Structure Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
    Via Finterra
    Topics Economy Intellectual Property
    News headline image
    Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
    From Structure Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position ↗
    Via The Motley Fool
    News headline image
    Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    The Trillion-Dollar Pharmaceutical Giant: Eli Lilly Makes History as Weight-Loss Revolution Drives Unprecedented Growth
    Via MarketMinute
    Topics Earnings Economy
    News headline image
    Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Structure Therapeutics Inc. - American Depositary Shares publicly traded?
    Yes, Structure Therapeutics Inc. - American Depositary Shares is publicly traded.
    What exchange does Structure Therapeutics Inc. - American Depositary Shares trade on?
    Structure Therapeutics Inc. - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Structure Therapeutics Inc. - American Depositary Shares?
    The ticker symbol for Structure Therapeutics Inc. - American Depositary Shares is GPCR on the Nasdaq Stock Market
    What is the current price of Structure Therapeutics Inc. - American Depositary Shares?
    The current price of Structure Therapeutics Inc. - American Depositary Shares is 38.91
    When was Structure Therapeutics Inc. - American Depositary Shares last traded?
    The last trade of Structure Therapeutics Inc. - American Depositary Shares was at 05/26/26 02:12 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.